...
首页> 外文期刊>The Journal of Antibiotics: An International Journal >Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activity.
【24h】

Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activity.

机译:在侧链的2'-酮基上修饰抗生素寡霉素I。新型衍生物,抗肿瘤和拓扑异构酶I中毒活性。

获取原文
获取原文并翻译 | 示例
           

摘要

A novel way of chemical modification of the antibiotic olivomycin I at the 2'-keto group of the side chain of the aglycone moiety was developed. Reaction of olivomycin I with the carboxymethoxylamine hemihydrochloride gave the key intermediate, 2'-carboxymethoxime-olivomycin I, which was further reacted with different amines in the presence of benzotriazol-1-yl-oxy-trispyrrolidinophosphonium hexafluorophosphate to give the corresponding amides. The antiproliferative and topoisomerase I (Topo-I)-poisoning activities of the novel derivatives were examined. One of the novel derivatives showed a marked inhibitory activity against Topo-I, a pronounced antitumor activity in in vivo experiments on mice bearing leukemia P-388 and lower toxic side effects compared with the parent olivomycin I.
机译:开发了在糖苷配基部分的侧链的2'-酮基上化学修饰抗生素寡霉素I的新方法。橄榄霉素I与羧甲氧基胺半盐酸盐的反应生成了关键中间体2'-羧甲基肟-橄榄霉素I,该中间体在六氟磷酸苯并三唑-1-基-氧基-三吡咯烷基磷鎓的存在下与不同的胺进一步反应,得到相应的酰胺。研究了新型衍生物的抗增殖和拓扑异构酶I(Topo-I)中毒活性。一种新的衍生物显示出对Topo-I的显着抑制活性,在体内实验中对患有白血病P-388的小鼠具有明显的抗肿瘤活性,并且与亲本寡霉素I相比,毒性副作用更低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号